Analgesics (Pharmacies) - Mauritius

  • Mauritius
  • Revenue in the Analgesics market is projected to reach US$5.85m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.35%, resulting in a market volume of US$8.34m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.49 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Mauritius is experiencing steady growth due to several factors.

Customer preferences:
Customers in Mauritius prefer to purchase analgesics from pharmacies rather than other retail outlets. This is because pharmacies are seen as more reliable and trustworthy sources for medication. Customers value the expertise of pharmacists who can provide advice and recommendations on the most suitable analgesics for their needs. Additionally, pharmacies in Mauritius often stock a wide range of analgesics, catering to different customer preferences and needs.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Mauritius is the increasing demand for over-the-counter (OTC) analgesics. OTC analgesics are medications that can be purchased without a prescription. This trend is driven by several factors. Firstly, customers in Mauritius are becoming more proactive in managing their health and are seeking immediate relief for common ailments such as headaches and muscle pain. OTC analgesics provide a convenient and accessible solution for these customers. Secondly, the growing awareness of the potential side effects and risks associated with prescription analgesics has led customers to prefer the safer and milder OTC options. Another trend in the market is the rising popularity of natural and herbal analgesics. Customers in Mauritius are increasingly seeking natural alternatives to traditional analgesics. This trend is driven by a growing awareness of the potential side effects of synthetic analgesics and a desire for more holistic approaches to healthcare. Pharmacies in Mauritius have responded to this trend by stocking a wider range of natural and herbal analgesics, providing customers with more choices.

Local special circumstances:
Mauritius is a popular tourist destination, attracting visitors from around the world. The tourism industry plays a significant role in the country's economy, and this has implications for the Analgesics (Pharmacies) market. Tourists visiting Mauritius may have different preferences and needs when it comes to analgesics. They may be more inclined to purchase familiar brands from their home countries or may require specific medications for pre-existing conditions. Pharmacies in Mauritius need to cater to the diverse needs of both locals and tourists, ensuring that they stock a wide range of analgesics from different brands and countries.

Underlying macroeconomic factors:
Mauritius has experienced steady economic growth in recent years, which has contributed to the growth of the Analgesics (Pharmacies) market. A growing economy means that people have more disposable income to spend on healthcare products, including analgesics. Additionally, the government of Mauritius has made efforts to improve access to healthcare services, including medication. This has led to an increase in the overall demand for analgesics in the country. In conclusion, the Analgesics (Pharmacies) market in Mauritius is developing due to customer preferences for pharmacies, the increasing demand for OTC and natural analgesics, the unique circumstances of the tourism industry, and the underlying macroeconomic factors. As the market continues to grow, pharmacies in Mauritius will need to adapt to changing customer preferences and cater to the diverse needs of both locals and tourists.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)